의료용 모노필라멘트 합성 흡수성 봉합사 시장 : 세계 예측(2026-2032년)

The Medical Monofilament Synthetic Absorbable Sutures Market is projected to grow by USD 1,086.55 million at a CAGR of 7.31% by 2032.

Medical Monofilament Synthetic Absorbable Sutures: Executive Overview

Medical monofilament synthetic absorbable sutures are sterile wound-closure devices designed to approximate tissue while gradually losing tensile strength and being absorbed by the body. Their use spans general surgery, obstetrics, gynecology, urology, orthopedics, cardiovascular procedures, and minimally invasive operations. Clinical selection depends on tissue type, healing time, handling characteristics, knot security, tissue response, infection-control requirements, and regulatory compliance.

Clinical Efficiency and Material Innovation Are Reshaping Suture Selection

The landscape is shifting toward atraumatic handling, predictable absorption profiles, low tissue reactivity, and reliable performance in minimally invasive procedures. Hospitals and surgical centers are also placing greater emphasis on standardized procurement, sterile packaging, traceability, and compatibility with increasingly specialized surgical workflows. Innovation is focused on polymer formulation, coating and surface treatment, needle-suture integration, packaging usability, and designs that support consistent placement while limiting avoidable tissue irritation.

Artificial Intelligence Supports Evidence Review, Quality Control, and Surgical Workflows

Artificial intelligence is influencing this market primarily through operational and analytical applications rather than replacing the clinical judgment required for suture selection. Machine-learning tools can help analyze procedure records, identify variation in product use, support inventory planning, and detect quality anomalies in manufacturing and packaging. Computer vision may assist inspection of needles, filaments, crimps, and sterile seals, while clinical decision-support systems can organize patient and procedural information. Adoption requires validated data, cybersecurity safeguards, explainable outputs, and compliance with medical-device regulations.

Regional Insights: Diverse Surgical Systems Shape Adoption Priorities

North America emphasizes evidence-based procurement, ambulatory surgery, infection prevention, and supply-chain resilience. Europe combines harmonized regulatory expectations with strong hospital purchasing controls and attention to sustainability. Asia-Pacific includes highly diverse healthcare systems, from advanced specialist hospitals to rapidly expanding surgical capacity, creating demand for dependable products across multiple price and clinical tiers. Latin America is influenced by public-sector purchasing, import conditions, and unequal access to advanced surgery. The Middle East is supported by investment in specialist hospitals and medical infrastructure, while Africa's priorities include affordability, reliable distribution, workforce training, and product availability in resource-constrained settings.

Group Insights: Trade and Policy Blocs Influence Procurement and Regulation

ASEAN markets reflect varied regulatory maturity, manufacturing capacity, and healthcare access, making registration efficiency and distributor capability important. BRICS members combine large and diverse healthcare systems with growing interest in domestic production, resilient supply chains, and broader surgical access. The European Union places weight on conformity, clinical evidence, traceability, and procurement transparency. G7 markets generally prioritize advanced surgical practice, rigorous quality systems, and value-based purchasing. GCC countries are strengthening tertiary-care capacity and often evaluate suppliers through centralized procurement and hospital accreditation requirements. NATO members span different health systems but share heightened attention to continuity of medical supply and emergency preparedness.

Country Insights: Regulatory Readiness and Surgical Capacity Define Local Priorities

Australia and Canada emphasize regulated procurement, clinical governance, and distribution reliability across geographically dispersed systems. Brazil, Mexico, and Russia face varied regional access conditions and place importance on dependable supply and public-sector purchasing. China and India combine expanding surgical capacity with domestic manufacturing and regulatory-development priorities. France, Germany, Italy, Spain, and the United Kingdom focus on hospital quality systems, evidence, traceability, and cost-conscious procurement within mature healthcare environments. Japan and South Korea emphasize precision manufacturing, advanced hospitals, quality assurance, and minimally invasive surgical practice. Across the United States, ambulatory surgery, contracting discipline, product standardization, and regulatory compliance strongly influence purchasing decisions.

Action Priorities for Leaders: Prove Clinical Value, Strengthen Supply, and Localize Execution

Industry leaders should align product portfolios with procedure-specific clinical needs rather than relying on broad claims. Priority actions include documenting tensile-strength retention and absorption behavior, strengthening usability evidence, improving needle and filament consistency, and maintaining robust sterile-barrier validation. Organizations should build regional regulatory and distribution plans, qualify alternate suppliers for critical materials, and use demand and quality data to reduce shortages and waste. AI-enabled tools should be introduced through controlled validation, cybersecurity review, and human oversight. Training for surgeons, nurses, and procurement teams can improve correct product selection and handling while reinforcing compliance.

Research Methodology: Evidence-Based Assessment of Product, Clinical, and Regional Drivers

This executive summary uses a structured qualitative assessment of medical monofilament synthetic absorbable sutures. The analysis considers product characteristics, surgical applications, clinical workflow, manufacturing and quality requirements, regulatory conditions, procurement practices, healthcare infrastructure, and regional access factors. Regional, group, and country perspectives are integrated to identify recurring adoption priorities without presenting market estimates, market sizing, market shares, forecasts, or company-specific claims. Artificial intelligence implications are assessed according to documented uses in healthcare operations, manufacturing inspection, analytics, and clinical decision support, with attention to validation and governance.

Conclusion: Reliable Performance and Evidence Will Define Sustainable Adoption

Medical monofilament synthetic absorbable sutures are positioned at the intersection of surgical efficiency, biomaterial performance, infection-control practice, and healthcare procurement discipline. The strongest strategic position will come from products supported by transparent evidence, consistent manufacturing, dependable sterile supply, and clear procedure-specific guidance. Regional execution must account for different regulatory pathways, infrastructure, purchasing models, and workforce needs. Leaders that combine clinical credibility with resilient operations and responsible digital adoption will be better prepared to serve evolving surgical systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Medical Monofilament Synthetic Absorbable Sutures Market, by Product Type

• 7.1. Introduction
• 7.2. Glycomer-631
• 7.3. Poliglecaprone-25
• 7.4. Polydioxanone
• 7.5. Polyglytone-6211

8. Medical Monofilament Synthetic Absorbable Sutures Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Online Stores
• 8.4. Retail Pharmacies

9. Medical Monofilament Synthetic Absorbable Sutures Market, by Application

• 9.1. Introduction
• 9.2. Cardiovascular Surgery
• 9.3. Gastrointestinal Surgery
• 9.4. General Surgery
• 9.5. Neurological Surgery
• 9.6. Obstetrics & Gynecology
• 9.7. Ophthalmic Surgery
• 9.8. Orthopedic Surgery
• 9.9. Plastic & Reconstructive Surgery
• 9.10. Urology

10. Medical Monofilament Synthetic Absorbable Sutures Market, by End User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Hospitals
• 10.4. Specialty Clinics

11. Medical Monofilament Synthetic Absorbable Sutures Market, by Region

• 11.1. Introduction
• 11.2. Asia-Pacific
• 11.3. North America
• 11.4. Latin America
• 11.5. Europe
• 11.6. Middle East
• 11.7. Africa

12. Medical Monofilament Synthetic Absorbable Sutures Market, by Group

• 12.1. Introduction
• 12.2. ASEAN
• 12.3. GCC
• 12.4. European Union
• 12.5. BRICS
• 12.6. G7
• 12.7. NATO

13. Medical Monofilament Synthetic Absorbable Sutures Market, by Country

• 13.1. Introduction
• 13.2. United States
• 13.3. Canada
• 13.4. Mexico
• 13.5. Brazil
• 13.6. United Kingdom
• 13.7. Germany
• 13.8. France
• 13.9. Russia
• 13.10. Italy
• 13.11. Spain
• 13.12. China
• 13.13. India
• 13.14. Japan
• 13.15. Australia
• 13.16. South Korea

14. Competitive Landscape

• 14.1. Market Share Analysis, 2025
• 14.2. Market Concentration Analysis, 2025
  • 14.2.1. Concentration Ratio (CR)
  • 14.2.2. Herfindahl Hirschman Index (HHI)
• 14.3. Recent Developments & Impact Analysis, 2025
• 14.4. Product Portfolio Analysis, 2025
• 14.5. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. B. Braun SE
• 15.2. CONMED Corporation
• 15.3. Corza Medical
• 15.4. DemeTECH Corporation
• 15.5. Dolphin Sutures
• 15.6. Genesis Medtech
• 15.7. Healthium Medtech Limited
• 15.8. Integra LifeSciences Corporation
• 15.9. Johnson & Johnson
• 15.10. Lotus Surgicals Pvt Ltd
• 15.11. MANI, Inc.
• 15.12. Medico
• 15.13. Medtronic plc
• 15.14. ORION SUTURES INDIA PVT. LTD.
• 15.15. Peters Surgical
• 15.16. Samyang Biopharmaceuticals
• 15.17. Smith & Nephew plc
• 15.18. Surgical Specialties Corporation
• 15.19. Teleflex Incorporated
• 15.20. Unisur Lifecare Pvt. Ltd.

16. Key Experts